Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Capsaicin is a naturally occurring active component of chili peppers (genus Capsicum) and is responsible for their characteristic heat. It is a highly pungent crystalline solid that acts as a potent irritant to mammals. In medicine and pharmacy it is used primarily as a topical analgesic for the relief of neuropathic pain conditions such as postherpetic neuralgia (pain after shingles), diabetic peripheral neuropathy of the feet and other types of nerve-related pain. Its mechanism involves activation and subsequent desensitization of the transient receptor potential vanilloid 1 (TRPV1) channel on sensory neurons; this leads to depletion of substance P—a neurotransmitter involved in transmitting pain signals—resulting in reduced sensation of pain over time. Topical formulations include creams/ointments/lotions at lower concentrations available over-the-counter for arthritis or muscle/joint pains; higher-concentration patches such as Qutenza are prescription-only and administered by healthcare professionals[1][3][6][7]. Beyond analgesia it has demonstrated anti-inflammatory and antioxidant properties in preclinical studies[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on capsaicin.